Endurant Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-42,762
Closed -$7.32M 76
2021
Q4
$7.32M Sell
42,762
-55,315
-56% -$9.06M 1.77% 18
2021
Q3
$15.8M Buy
98,077
+65,079
+197% +$11.1M 3.61% 6
2021
Q2
$5.44M Buy
32,998
+4,144
+14% +$686K 1.49% 28
2021
Q1
$4.74M Sell
28,854
-27,377
-49% -$4.43M 1.24% 32
2020
Q4
$8.85M Sell
56,231
-18,748
-25% -$2.77M 3.19% 6
2020
Q3
$11.2M Sell
74,979
-8,900
-11% -$1.32M 3.3% 10
2020
Q2
$11.8M Buy
83,879
+35,388
+73% +$5.16M 0.65% 6
2020
Q1
$6.36M Buy
+48,491
New +$6.88M 2.88% 13
2019
Q4
Sell
-107,413
Closed -$13.9M 65
2019
Q3
$13.9M Buy
+107,413
New +$14.2M 4.99% 8
2019
Q1
Sell
-6,588
Closed -$850K 79
2018
Q4
$850K Buy
6,588
+4,119
+167% +$575K 0.45% 38
2018
Q3
$341K Sell
2,469
-56,158
-96% -$7.46M 0.15% 70
2018
Q2
$7.11M Sell
58,627
-55,484
-49% -$6.92M 3.08% 10
2018
Q1
$14.6M Buy
114,111
+53,311
+88% +$7.21M 5.46% 3
2017
Q4
$8.49M Buy
60,800
+4,300
+8% +$599K 2.6% 12
2017
Q3
$7.35M Buy
+56,500
New +$7.49M 2.23% 16
2017
Q2
Sell
-10,100
Closed -$1.26M 97
2017
Q1
$1.26M Buy
10,100
+1,700
+20% +$203K 0.4% 61
2016
Q4
$968K Sell
8,400
-8,500
-50% -$982K 0.4% 51
2016
Q3
$2M Sell
16,900
-7,600
-31% -$922K 0.74% 37
2016
Q2
$2.97M Buy
+24,500
New +$2.78M 0.99% 33
2016
Q1
Sell
-5,800
Closed -$596K 88
2015
Q4
$596K Sell
5,800
-54,100
-90% -$5.44M 0.2% 67
2015
Q3
$5.59M Sell
59,900
-18,700
-24% -$1.81M 1.87% 17
2015
Q2
$7.66M Buy
78,600
+64,800
+470% +$6.49M 2.26% 13
2015
Q1
$1.39M Buy
13,800
+8,500
+160% +$864K 0.46% 61
2014
Q4
$554K Buy
+5,300
New +$559K 0.22% 78

Other funds holding JNJ

Endurant Capital Management's JNJ Position: Q1 2022 in Review

Endurant Capital Management sold out of Johnson & Johnson (JNJ) in Q1 2022, closing a stake of 42,762 shares — an estimated $7.32M sold.

Endurant Capital Management first reported a position in JNJ in Q4 2014 and held it in 24 quarters. The position peaked at $15.8M in Q3 2021. 3,677 funds tracked by Wall St. Rank hold JNJ as of Q1 2022.

  • Endurant Capital Management reported no remaining Johnson & Johnson position as of Q1 2022 after selling out during the quarter.
  • Endurant Capital Management sold 42,762 Johnson & Johnson shares in Q1 2022, an estimated $7.32M.
  • Endurant Capital Management first reported a position in Johnson & Johnson in Q4 2014 and held it in 24 quarters.
  • Endurant Capital Management's Johnson & Johnson position peaked at $15.8M in Q3 2021.
  • 3,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2022.

Based on Endurant Capital Management's 13F filing for Q1 2022, filed 16 May 2022.